MarginsXMarginsX
Home › Markets › Health Care › LUCY

Innovative Eyewear Inc. (LUCY)

LUCY trades on Nasdaq in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.7820
-3.25% on the day
Market cap
$6.8M
Nano cap
Revenue · 2025
$2.7M
+62.6% on 2024
Net income · 2025
-$7.6M
-285.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1808377/000182912626002695/0001829126-26-002695-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerLUCY on Nasdaq
SectorHealth Care
IndustryOphthalmic Goods
CountryUnited States
IPO year2022
SEC CIK0001808377
SEC industry codeOphthalmic Goods
Incorporated inFL

Financials · 2025

LineValue
Revenue$2.7M
Net income-$7.6M
Operating incomeNot in SEC XBRL data
Net margin-285.2%
Operating marginOperating income not reported
Revenue growth+62.6%
Cash$6.5M
Total assets$10.1M
P/E (computed)Net income was not positive
P/S (computed)2.6×

Warning signs

Cash runway
5.3 months
$3.2M cash at September 30, 2026
Share count, 1 year
+62.8%
2025-11-06 to 2026-11-09 · +1248.9% over 3 years
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
$1.5M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$3.2M cash; operating cash flow -$1.8M a quarter.Report 2026-09-30
Shares outstanding8,712,263 (2026-11-09); 5,350,183 a year earlier; 12,917,239 three years earlier. 3y figure adjusted for split (1-for-20 overall).Cover page 2026-11-09
Reverse splits, 3 years1; latest 1-for-20 on 2024-07-18Source 2024-07-18
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-10-15
AuditorCherry Bekaert LLP, Chicago, Illinois, United StatesPCAOB Form AP 2026-03-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.6M, sold $76K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.0M-$2.3M-$1.5M$3.2MNo debt tags$3.8M10-Q 2026-11-09
Q2 2026
2026-06-30
$1.0M-$1.7M-$1.9M$2.5MNo debt tags$3.4M10-Q 2026-08-14
Q1 2026
2026-03-31
$774K-$2.3M-$2.5M$4.4MNo debt tags$3.0M10-Q 2026-05-14
Q4 2025
2025-12-31
$960K-$1.9M-$1.4M$6.5MNo debt tags$2.7M10-K 2026-03-25
Q3 2025
2025-09-30
$668K-$1.8M-$1.5M$6.7MNo debt tags$2.4M10-Q 2026-11-09
Q2 2025
2025-06-30
$579K-$2.1M-$2.1M$7.6MNo debt tags$2.0M10-Q 2026-08-14
Q1 2025
2025-03-31
$455K-$1.8M-$2.3M$5.3MNo debt tags$1.7M10-Q 2026-05-14
Q4 2024
2024-12-31
$691K-$2.1M-$1.9M$2.6MNo debt tags$1.6M10-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12026-07-23
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-10-15
Latest proxyDEF 14A2026-10-05

Source: SEC EDGAR submissions feed, 266 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.1%
1 month-5.2%
3 months+7.2%
Year to date-19.0%
1 year-47.9%
From 52-week high-53.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
LUCYWInnovative Eyewear Inc. Series A Warrants 8/16/27$0.0281

Peers in Ophthalmic Goods

TickerCompanyPriceDayMarket cap
RXSTRxSight Inc.$5.30-0.38%$222.2M
STAASTAAR Surgical Company$26.01-1.44%$1.3B
EYENational Vision Holdings Inc.$18.74+2.43%$1.5B
WRBYWarby Parker Inc.$26.23-4.41%$3.3B
BLCOBausch + Lomb Corporation Common Shares$20.88-1.00%$7.5B
COOThe Cooper Companies Inc.$61.88-1.23%$11.8B
ALCAlcon Inc.$73.64-0.65%$36.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier